Zai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid Tumors
ZL-1310 is an innovative ADC targeting DLL3, a promising therapeutic target in small cell lung…
2 years ago
Wire Stories
Gold Resource Corporation Reports Results of Operations for the Year Ended December 31, 2023
DENVER--(BUSINESS WIRE)--Gold Resource Corporation (NYSE American: GORO) (the “Companyâ€) is pleased to announce its full-year…
2 years ago
Entravision Mobile Growth Solutions is Renaming its Mobile App Promotion Division to Adwake
Headquartered in Barcelona, Spain, Adwake leads tech-driven global services SANTA MONICA, Calif.--(BUSINESS WIRE)--Entravision, a global…
2 years ago
Asia Pacific Tire Market Report 2024: Analysis by Radial/Bias Tires, End-Use, Vehicle Type, Size, Distribution Channel, and Country 2023-2032 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Tire Market Report by Radial/Bias Tires, End-Use, Vehicle Type, Size, Distribution…
2 years ago
Asia-Pacific 2D Materials Market Analysis and Forecasts, 2022-2023 and 2031: Emergence of Hybrid Technology, Recent Investments in 2D Materials, Emerging Start-Up Companies – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific 2D Materials Market - Analysis and Forecast, 2022-2031" report has been added…
2 years ago
Flecha Azul Tequila Leads the Additive-Free Tequila Movement Abroad Launching in Australia
The brand, marketing its third international market, will expand its footprint in Australia through a…
2 years ago
First Doses of BRUKINSA® provided to Patients with Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries Under Collaboration of The Max Foundation, BeiGene, and the BeiGene Foundation
Armenia and Nepal are the first of 29 countries to receive BRUKINSA SEATTLE & BASEL,…
2 years ago
Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia
− Pre-Specified Interim Analysis Shows Positive Safety and Efficacy Results; Mezagitamab Safe and Well Tolerated…
2 years ago
Sapia.ai Unveils SAIGEâ„¢: A world-first Gen AI-powered conversational intelligence engine for talent management
MELBOURNE, Australia--(BUSINESS WIRE)--#AI--Sapia.ai, a leader in workplace artificial intelligence (AI) solutions, today launches SAIGEâ„¢, a…
2 years ago
Asia-Pacific TOPCon (Tunnel Oxide Passivated Contact) Solar Cells Industry Report 2023: Rising Need for Solar Cells with Flexible Manufacturing Processes and Great Efficiency – Forecasts to 2032 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific TOPCon Solar Cells Market - Analysis and Forecast, 2023-2032" report has been…
2 years ago